Table 4.
The proportion (%, SE) with cognitive impairment in the total population by A1c level among adults age ≥60 years, NHANES 2011–2014
| A1c< 7.0% (<53 mmol/mol) | A1c 7.0– <8.0% (53– <64 mmol/mol) | A1c ≥8.0% (≥64 mmol/mol) | |
|---|---|---|---|
| CERAD WL Delayed | |||
| Model 1 | 4.5 (0.70) | 3.5 (1.56) | 9.7 (3.73) |
| Model 2 | 4.5 (0.70) | 3.5 (1.55) | 9.6 (3.81) |
| Model 3 | 4.5 (0.70) | 2.5 (1.54) | 9.8 (3.98) |
| Model 4 | 4.0 (0.70) | 2.3 (1.62) | 8.9 (3.72) |
| Model 5 | 3.9 (0.69) | 3.2 (1.67) | 9.6 (3.71) |
| Model 6 | 4.0 (0.73) | 2.0 (1.32) | 9.4 (3.70) |
| Model 7 | 4.0 (0.72) | 2.1 (1.38) | 9.3 (3.67) |
| CERAD WL Total | |||
| Model 1 | 5.4 (0.85) | 3.0 (1.56) | 11.4 (4.59) |
| Model 2 | 5.4 (0.85) | 2.9 (1.57) | 11.2 (4.56) |
| Model 3 | 5.5 (0.86) | 1.9 (1.59) | 11.5 (4.77) |
| Model 4 | 5.2 (0.86) | 1.5 (1.70) | 10.4 (4.52) |
| Model 5 | 5.1 (0.87) | 2.4 (1.91) | 11.1 (4.38) |
| Model 6 | 5.1 (0.91) | 1.3 (1.43) | 11.0 (4.58) |
| Model 7 | 5.1 (0.91) | 1.2 (1.49) | 11.1 (4.61) |
| Animal Fluency | |||
| Model 1 | 5.5 (1.02) | 6.5 (2.35) | 6.6 (2.75) |
| Model 2 | 5.5 (1.01) | 6.5 (2.34) | 6.6 (2.84) |
| Model 3 | 5.1 (1.01) | 4.8 (2.28) | 6.9 (2.93) |
| Model 4 | 4.7 (0.94) | 3.8 (2.83) | 6.6 (2.94) |
| Model 5 | 4.4 (0.84) | 3.5 (2.68) | 7.0 (3.13) |
| Model 6 | 4.6 (0.87) | 3.2 (2.94) | 6.7 (3.11) |
| Model 7 | 4.6 (0.87) | 2.7 (2.78) | 7.2 (3.09) |
| DSST | |||
| Model 1 | 7.4 (1.16) | 5.7 (1.36) | 14.8 (4.20) |
| Model 2 | 7.4 (1.16) | 5.7 (1.35) | 14.9 (4.18) |
| Model 3 | 7.0 (1.09) | 4.0 (1.63) | 14.5 (3.97) |
| Model 4 | 6.5 (1.02) | 3.4 (1.85) | 14.5 (4.14) * |
| Model 5 | 6.2 (0.94) | 3.2 (2.10) | 14.9 (4.10) * |
| Model 6 | 6.3 (0.97) | 2.3 (1.82) | 14.7 (4.17) * |
| Model 7 | 6.3 (0.98) | 2.3 (1.72) | 14.6 (4.26) * |
p<0.05 vs. A1c <7.0%
Cognitive impairment defined as ≤1.5 SD of the mean cognitive test score for the NHANES population
Model 1: Adjusted for age, race/ethnicity
Model 2: Model 1 + sex
Model 3: Model 2 + education, income
Model 4: Model 3 + smoking status, alcohol consumption, exercise
Model 5: Model 4 + body mass index
Model 6: Model 5 + hypertension, hyperlipidemia, history of CVD
Model 7: Model 6 + depression, history of stroke